Company Filing History:
Years Active: 2011-2013
Title: Innovations and Contributions of Nicholas Marcopulos
Introduction
Nicholas Marcopulos is a notable inventor based in North Caldwell, NJ (US), recognized for his significant contributions to the field of pharmaceuticals. With a total of four patents to his name, he has made strides in developing compounds that address critical health issues.
Latest Patents
Among his latest patents, the invention of aminomethyl quinolone compounds stands out. This invention relates to JNK inhibitors and corresponding methods, formulations, and compositions for inhibiting JNK and treating JNK-mediated disorders. The application discloses JNK inhibitors, which are useful for modulating the activity of JNK and treating diseases associated with JNK activity. Additionally, he has developed diacylglycerol acyltransferase inhibitors, which are active as DGAT inhibitors. These compounds are significant in treating diseases associated with abnormal metabolism of triglycerides, such as obesity, type II diabetes mellitus, and metabolic syndrome.
Career Highlights
Throughout his career, Nicholas has worked with prominent companies, including Hoffmann-La Roche Inc. and Madrigal Pharmaceuticals, Inc. His work in these organizations has contributed to advancements in pharmaceutical research and development.
Collaborations
Nicholas has collaborated with esteemed colleagues, including Adrian Wai-Hing Cheung and Fariborz Firooznia. These partnerships have fostered innovation and enhanced the impact of his inventions.
Conclusion
Nicholas Marcopulos is a distinguished inventor whose work in developing pharmaceutical compounds has the potential to address significant health challenges. His contributions through patents and collaborations highlight his commitment to innovation in the field.